8-KMaterial AgreementsFinancial EventsExhibits & Filings

HCA Healthcare, Inc. 8-K Report, Material Agreement (Jun 30, 2017)

Filed June 30, 2017For Securities:HCA

Summary

This 8-K filing by HCA Healthcare, Inc. (HCA) on June 30, 2017, details significant amendments to its credit facilities, aimed at enhancing financial flexibility and extending debt maturities. Specifically, the company has restructured both its Senior Secured Revolving Credit Facility (Cash Flow Credit Agreement) and its Asset-Based Lending Facility (ABL Facility). These restatements are crucial for investors as they indicate proactive management in optimizing the company's capital structure and ensuring access to funding.

Key Highlights

  • 1HCA Inc., a subsidiary of HCA Healthcare, Inc., entered into a Restatement Agreement for its Cash Flow Credit Agreement on June 28, 2017.
  • 2The Cash Flow Credit Agreement's revolving credit commitments maturity date has been extended to June 28, 2022.
  • 3Provisions for incremental credit facilities have been amended to allow for an additional $1.5 billion in principal amount.
  • 4HCA Inc. also entered into a Restatement Agreement for its ABL Credit Agreement on June 28, 2017.
  • 5The ABL Facility's total commitments have been increased from $3.25 billion to $3.75 billion.
  • 6The maturity date for the ABL Facility's revolving credit commitments has also been extended to June 28, 2022.
  • 7The ABL Facility's incremental facility provisions were amended to allow for an additional $1.5 billion in principal amount.

Frequently Asked Questions

The primary changes involve extending the maturity dates of both the Senior Secured Revolving Credit Facility and the Asset-Based Lending Facility to June 28, 2022. Additionally, the agreements have been amended to permit the incurrence of new incremental credit facilities, totaling up to $1.5 billion for each agreement when combined. The ABL Facility's overall commitment amount has also been increased.

Extending credit maturities demonstrates proactive financial management. It provides HCA with greater financial stability and flexibility by ensuring access to significant credit lines for a longer period, reducing near-term refinancing risks and supporting ongoing operations and potential growth initiatives.

Increasing the ABL Facility commitment from $3.25 billion to $3.75 billion provides HCA with greater liquidity. This expanded access to capital can be used for working capital needs, strategic investments, or other corporate purposes, signaling financial strength and capacity.

The amendments allow for the incurrence of additional incremental credit facilities, suggesting HCA has the option to access more capital if needed. However, the filing itself doesn't indicate an immediate plan to draw on these facilities. It provides HCA with strategic flexibility for future financing needs.